Current Number Of Drug Injury Lawsuits Filed In Each Of These Ongoing Federal Court MDL Cases: February 2018 JPML Report

 

(Posted by Tom Lamb at DrugInjuryWatch.com)

 

At the present time there are four federal court Multidistrict Litigation (MDL) cases for drug injury lawsuits concerning several different types of diabetes medicines with unique sets of side effects.

From the February 15, 2018 version of this document, "MDL Statistics Report – Distribution of Pending MDL Dockets by Actions Pending" (accessed 2/21/18), published by the United States Judicial Panel on Multidistrict Litigation (JPML), we get the current number of cases filed in each of these diabetes drugs MDL cases.

We supplement that information provided by the JPML with the primary side effects that are the subject of personal injury lawsuits and wrongful death lawsuits filed in each of these diabetes drug MDL cases.

---

IN RE: Incretin-Based Therapies Products Liability Litigation  MDL-2452

Number of lawsuits pending: 936

Diabetes drugs in this MDL case: 

• Byetta (exenatide)
• Bydureon (exenatide)
• Victoza (liraglutide)
• Januvia (sitagliptin)
• Janumet (sitagliptin)
• Janumet XR (sitagliptin)
• Juvisync (sitagliptin)

Primary side effect for these cases:

• Pancreatic Cancer, also known as Pancreas Cancer

Get more information about these drug injury cases and/or free case evaluation.

---

IN RE: Invokana (Canagliflozin) Products Liability Litigation  MDL-2750

Number of lawsuits pending: 985

Diabetes drugs in this MDL case:

• Invokana (canagliflozin)
• Invokamet (canagliflozin and metformin)
• Invokamet XR (canagliflozin and metformin extended-release)

Primary side effects for these cases:

• Diabetic Ketoacidosis (DKA)
• Ketoacidosis
• Ketosis
• Leg Amputation
• Foot or Toe(s) Amputation

Get more information about these drug injury cases and/or free case evaluation.

 

---

 

IN RE: Farxiga (Dapagliflozin) Products Liability Litigation  MDL-2776 

Number of lawsuits pending: 51
Diabetes drugs in this MDL case:

• Farxiga (dapagliflozin)
• Xigduo XR (dapagliflozin and metformin extended-release)
• Qtern (dapagliflozin and saxagliptin)

Primary side effects for these cases:

• Diabetic Ketoacidosis (DKA)
• Ketoacidosis
• Ketosis

Get more information about these drug injury cases and/or free case evaluation.

 

---

 

IN RE: Onglyza (Saxagliptin) and Kombiglyze XR (Saxagliptin and Metformin) Products Liability Litigation  MDL-2809 

Number of lawsuits pending: 84
Diabetes drugs in this MDL case:

• Onglyza (saxagliptin)
• Kombiglyze XR (saxagliptin and metformin)

Primary side effect for these cases:

• Heart Failure

Get more information about these drug injury cases and/or a free case evaluation.

 

---

 

We will continue to monitor the number of pending lawsuits in these four distinct diabetes drugs MDL cases and watch for significant developments in each of these federal court MDL litigations.

DrugInjuryLaw.com: Medical & Legal Information About Drug Side Effects  (All website content by attorney Tom Lamb)

Drug Injury Case Evaluation - Free. Confidential. No Obligation.  (Case review done by attorney Tom Lamb)